<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01837680</url>
  </required_header>
  <id_info>
    <org_study_id>12-166</org_study_id>
    <nct_id>NCT01837680</nct_id>
  </id_info>
  <brief_title>Glycemic Control Using Insulin Levemir Versus Insulin NPH for Diabetes in Pregnancy</brief_title>
  <official_title>Insulin Detemir Versus Insulin NPH: A Randomized Prospective Study Comparing Glycemic Control in Pregnant Women With Diabetes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. Luke's-Roosevelt Hospital Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>St. Luke's-Roosevelt Hospital Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to compare glycemic control in pregnant women treated with insulin
      Detemir and pregnant women treated with NPH insulin. These women are diagnosed with
      gestational diabetes (GDM) in the current pregnancy or have a preexisting diagnosis of type 2
      diabetes (T2DM) at the onset of pregnancy. Our hypothesis is that there is no difference
      between these two treatment modalities in terms of glycemic control in diabetes.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The experimental method will be a randomized controlled trial performed at Roosevelt Hospital
      in our Diabetes in Pregnancy Program (DIPP). Perinatologists managing the patient in DIPP
      determine when patients need further treatment with medical therapy. Patients undergoing care
      at DIPP may require medical intervention in the following clinical scenarios: failure of diet
      alone to control glycemic indices and grossly abnormal glucose tolerance screening test
      results suggesting disease of such severity that diet alone would not be sufficient. After
      verbally counseling the patient, she will be recruited for the study by the investigators. An
      extensive explanation of the objectives of the study will be presented to the patient, as
      well as written copies of the protocol and consent. After informed consent is given, patients
      will be randomized to management with either insulin NPH or detemir together with rapid
      acting insulin aspart (Novolog) with meals, as necessary. The primary outcome will be level
      of glycemic control defined as overall mean blood glucose in pregnancy. This is a well
      established measure of overall glycemic control that has been used in numerous publications
      in the obstetric literature on diabetes in pregnancy. Participants will be followed until
      they deliver, with an expected range of 6-16 weeks depending on when the patient was enrolled
      in the study. The mean glucose will be determined by the sum of average glucose at each visit
      divided by the number of visits).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2013</start_date>
  <completion_date type="Actual">March 2015</completion_date>
  <primary_completion_date type="Actual">March 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Glycemic Control</measure>
    <time_frame>up to 41 weeks</time_frame>
    <description>Overall mean glucose value of pregnancy. This will be determined by the sum of average glucose value at each visit, divided by the number of visits.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Patients Obtaining Glycemic Control</measure>
    <time_frame>up to 41 weeks</time_frame>
    <description>Number of each group that obtains glycemic control, defined as mean glucose &lt;100mg/dl.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to Achieve Glycemic Control</measure>
    <time_frame>up to 41 weeks</time_frame>
    <description>Time (weeks) to achieve glycemic control, as defined as mean glucose &lt;100mg/dl</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Average Fasting Glucose</measure>
    <time_frame>up to 41 weeks</time_frame>
    <description>Mean fasting blood glucose in pregnancy, as determined by the sum of the mean fasting glucose at each visit divided by the number of visits</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-prandial Blood Glucose</measure>
    <time_frame>up to 41 weeks</time_frame>
    <description>Mean post-prandial blood glucose in pregnancy, as defined as the sum of the average post-prandial blood glucose at each visit divided by the number of visits.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Weight Gain</measure>
    <time_frame>Number of pounds gained at each visit up to 41 weeks</time_frame>
    <description>Total weight gain in pregnancy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neonatal Weight</measure>
    <time_frame>At delivery, up to 41 weeks</time_frame>
    <description>Neonatal weight was estimated for occurrence of neonatal macrosomia (≥4000g birth weight) and neonatal LGA(large for gestational age)(birth weight &gt;90th percentile for gestational age</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gestational Age at Delivery</measure>
    <time_frame>at delivery, up to 41 weeks</time_frame>
    <description>Gestational age at delivery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maternal Hypoglycemia</measure>
    <time_frame>at delivery, up to 41 weeks</time_frame>
    <description>Number of participants with incidence of maternal hypoglycemia (&lt;60mg/dl)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neonatal Bilirubin</measure>
    <time_frame>at birth, up to 41 weeks</time_frame>
    <description>Percentage of neonatal hyperbilirubinemia - data not collected</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intensive Care Admissions</measure>
    <time_frame>at birth, up to 41 weeks</time_frame>
    <description>Number of participants with incidence of neonatal intensive care unit admissions</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Delivery Mode</measure>
    <time_frame>at birth, up to 41 weeks</time_frame>
    <description>method of delivery including cesarean section, vaginal delivery, or assisted vaginal delivery - data not collected</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Birth Rate</measure>
    <time_frame>at birth, up to 41 weeks</time_frame>
    <description>Number of live birth rate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Shoulder Dystocia</measure>
    <time_frame>at birth, up to 41 weeks</time_frame>
    <description>Incidence of shoulder dystocia - data not collected</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Polyhydramnios</measure>
    <time_frame>at each visit in pregnancy up to 41 weeks</time_frame>
    <description>Incidence of polyhydramnios (defined as amniotic fluid index (AFI)&gt;20 or deepest vertical pocket ≥8) - data not collected</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neonatal Hypoglycemia</measure>
    <time_frame>at birth, up to 41 weeks</time_frame>
    <description>Number of participants with incidence of blood sugar &lt;40mg/dl in neonate</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">105</enrollment>
  <condition>Diabetes, Gestational</condition>
  <condition>Diabetes, Type 2</condition>
  <arm_group>
    <arm_group_label>Levemir</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Initial daily total insulin doses will be determined as per a weight based protocol depending on what trimester the patient is in. Sixty percent of the total daily insulin dose will be allotted to the morning total dose of insulin, while the remaining 40% will be allotted to the evening total dose. Of the morning dose, 2/3 will be allotted to the long acting insulin and 1/3 to short acting insulin. She will take half of the short-acting dose with breakfast and the other half with lunch. The evening insulin dose (40% of the total dose) will be divided in two: half the dose will be taken as short-acting insulin with dinner, and the other half as long acting insulin at bedtime. Doses are rounded down if decimals are present.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>NPH</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Initial daily total insulin doses will be determined as per a weight based protocol depending on what trimester the patient is in. Sixty percent of the total daily insulin dose will be allotted to the morning total dose of insulin, while the remaining 40% will be allotted to the evening total dose. Of the morning dose, 2/3 will be allotted to the long acting insulin and 1/3 to short acting insulin. She will get the entire dose of short-acting insulin with breakfast. The evening insulin dose (40% of the total dose) will be divided in two: half the dose will be taken as short-acting insulin with dinner, and the other half as long acting insulin at bedtime. Doses are rounded down if decimals are present.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Insulin</intervention_name>
    <arm_group_label>Levemir</arm_group_label>
    <arm_group_label>NPH</arm_group_label>
    <other_name>Insulin NPH</other_name>
    <other_name>Insulin Levemir</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:

          -  All pregnant women with a viable singleton or multiple gestation at ≤34 weeks with
             gestational diabetes diagnosed in their current pregnancy requiring medical therapy.
             &quot;Early diagnosis&quot; GDM patients will also be included; which is defined as a diagnosis
             made prior to 24 weeks.

          -  Women with known preexisting type 2 diabetes that are in need of medical therapy.

        Exclusion criteria:

          -  Patients &lt;18 years of age

          -  a diagnosis of GDM outside of the gestational age stated above

          -  known allergy/prior adverse reaction to insulin NPH or insulin detemir.

          -  type 1 diabetes
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>St. Luke's-Roosevelt Hospital Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10019</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 4, 2013</study_first_submitted>
  <study_first_submitted_qc>April 22, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 23, 2013</study_first_posted>
  <results_first_submitted>January 12, 2017</results_first_submitted>
  <results_first_submitted_qc>May 24, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">May 30, 2017</results_first_posted>
  <last_update_submitted>May 24, 2017</last_update_submitted>
  <last_update_submitted_qc>May 24, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 30, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Insulin, Long-Acting</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes, Gestational</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin, Globin Zinc</mesh_term>
    <mesh_term>Isophane insulin, beef</mesh_term>
    <mesh_term>Insulin</mesh_term>
    <mesh_term>Insulin Detemir</mesh_term>
    <mesh_term>Isophane Insulin, Human</mesh_term>
    <mesh_term>Insulin, Isophane</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Women with gestational diabetes mellitus (GDM) and type 2 diabetes mellitus (T2DM) who entered the Diabetes in Pregnancy Program were recruited from March 2013 through October 2014</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Insulin NPH</title>
          <description>Insulin neutral protamine Hagedorn (NPH) - Current weight was obtained at the visit and initial daily total insulin dose was determined based on patient weight (in kilograms) and trimester. In the first trimester, patient weight was multiplied by 0.7, in the second trimester by 0.8, and in the third trimester by 0.9 for the total daily dose of insulin (in units). Of the total daily insulin dose, 60% was allotted to the morning total dose of insulin, while the remaining 40% allotted to the evening total dose.</description>
        </group>
        <group group_id="P2">
          <title>Levemir</title>
          <description>Insulin detemir (IDet) - Current weight was obtained at the visit and initial daily total insulin dose was determined based on patient weight (in kilograms) and trimester. In the first trimester, patient weight was multiplied by 0.7, in the second trimester by 0.8, and in the third trimester by 0.9 for the total daily dose of insulin (in units). Of the total daily insulin dose, 60% was allotted to the morning total dose of insulin, while the remaining 40% allotted to the evening total dose.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="52"/>
                <participants group_id="P2" count="53"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="42"/>
                <participants group_id="P2" count="45"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="8"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>lack of insurance</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>allergic reaction</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>switched to oral hypoglycemic or diet</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="4"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Insulin NPH</title>
          <description>Insulin neutral protamine Hagedorn</description>
        </group>
        <group group_id="B2">
          <title>Levemir</title>
          <description>Insulin detemir (IDet)</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="42"/>
            <count group_id="B2" value="45"/>
            <count group_id="B3" value="87"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="35" lower_limit="31" upper_limit="38"/>
                    <measurement group_id="B2" value="35" lower_limit="32" upper_limit="38"/>
                    <measurement group_id="B3" value="35" lower_limit="31" upper_limit="38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="42"/>
                    <measurement group_id="B2" value="45"/>
                    <measurement group_id="B3" value="87"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="17"/>
                    <measurement group_id="B3" value="28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Black</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hispanic</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Native American/Alaskan</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Biracial/Multiracial</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>T2DM</title>
          <description>Type 2 Diabetes Mellitus</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>GDM in previous pregnancies</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Multiple gestation</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Polycystic ovary syndrome</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Chronic hypertension</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Renal disease</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Thyroid disease</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Prepregnancy body mass index</title>
          <units>kg/m^2</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="28.3" lower_limit="24.9" upper_limit="33.8"/>
                    <measurement group_id="B2" value="28.6" lower_limit="24.4" upper_limit="31.1"/>
                    <measurement group_id="B3" value="28.4" lower_limit="24.5" upper_limit="32.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Prepregnancy body status</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Normal</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="14"/>
                    <measurement group_id="B3" value="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Obese</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Overweight</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="16"/>
                    <measurement group_id="B3" value="28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Morbidly obese</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gestational age diagnosed</title>
          <units>weeks</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="26.1" lower_limit="24.8" upper_limit="27.1"/>
                    <measurement group_id="B2" value="26.6" lower_limit="25.4" upper_limit="28.2"/>
                    <measurement group_id="B3" value="26.3" lower_limit="25.2" upper_limit="27.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Previous management</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Diet</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="35"/>
                    <measurement group_id="B2" value="39"/>
                    <measurement group_id="B3" value="74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Diet, Metformin</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Glyburide</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Metformin</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Metformin and glyburide</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other type of insulin</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gestational age at entry to DIPP</title>
          <units>weeks</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="27.3" lower_limit="23.3" upper_limit="28.5"/>
                    <measurement group_id="B2" value="28.1" lower_limit="25.1" upper_limit="29.3"/>
                    <measurement group_id="B3" value="27.5" lower_limit="24.1" upper_limit="29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gestational age insulin started</title>
          <units>weeks</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="29.6" lower_limit="27.5" upper_limit="31.4"/>
                    <measurement group_id="B2" value="30.0" lower_limit="25.1" upper_limit="31.5"/>
                    <measurement group_id="B3" value="30.0" lower_limit="27.3" upper_limit="31.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Time between visits</title>
          <units>weeks</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1.5" lower_limit="1.3" upper_limit="2.0"/>
                    <measurement group_id="B2" value="1.5" lower_limit="1.3" upper_limit="1.8"/>
                    <measurement group_id="B3" value="1.5" lower_limit="1.3" upper_limit="1.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Glycemic Control</title>
        <description>Overall mean glucose value of pregnancy. This will be determined by the sum of average glucose value at each visit, divided by the number of visits.</description>
        <time_frame>up to 41 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Insulin NPH</title>
            <description>Insulin neutral protamine Hagedorn</description>
          </group>
          <group group_id="O2">
            <title>Levemir</title>
            <description>Insulin detemir (IDet)</description>
          </group>
        </group_list>
        <measure>
          <title>Glycemic Control</title>
          <description>Overall mean glucose value of pregnancy. This will be determined by the sum of average glucose value at each visit, divided by the number of visits.</description>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="42"/>
                <count group_id="O2" value="45"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="109.5" spread="10.0"/>
                    <measurement group_id="O2" value="107.4" spread="7.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Patients Obtaining Glycemic Control</title>
        <description>Number of each group that obtains glycemic control, defined as mean glucose &lt;100mg/dl.</description>
        <time_frame>up to 41 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Insulin NPH</title>
            <description>Insulin neutral protamine Hagedorn</description>
          </group>
          <group group_id="O2">
            <title>Levemir</title>
            <description>Insulin detemir (IDet)</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Patients Obtaining Glycemic Control</title>
          <description>Number of each group that obtains glycemic control, defined as mean glucose &lt;100mg/dl.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="42"/>
                <count group_id="O2" value="45"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28"/>
                    <measurement group_id="O2" value="35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time to Achieve Glycemic Control</title>
        <description>Time (weeks) to achieve glycemic control, as defined as mean glucose &lt;100mg/dl</description>
        <time_frame>up to 41 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Insulin NPH</title>
            <description>Insulin neutral protamine Hagedorn</description>
          </group>
          <group group_id="O2">
            <title>Levemir</title>
            <description>Insulin detemir (IDet)</description>
          </group>
        </group_list>
        <measure>
          <title>Time to Achieve Glycemic Control</title>
          <description>Time (weeks) to achieve glycemic control, as defined as mean glucose &lt;100mg/dl</description>
          <units>weeks</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="42"/>
                <count group_id="O2" value="45"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5" lower_limit="3" upper_limit="9"/>
                    <measurement group_id="O2" value="5" lower_limit="4" upper_limit="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Average Fasting Glucose</title>
        <description>Mean fasting blood glucose in pregnancy, as determined by the sum of the mean fasting glucose at each visit divided by the number of visits</description>
        <time_frame>up to 41 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Insulin NPH</title>
            <description>Insulin neutral protamine Hagedorn</description>
          </group>
          <group group_id="O2">
            <title>Levemir</title>
            <description>Insulin detemir (IDet)</description>
          </group>
        </group_list>
        <measure>
          <title>Average Fasting Glucose</title>
          <description>Mean fasting blood glucose in pregnancy, as determined by the sum of the mean fasting glucose at each visit divided by the number of visits</description>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="42"/>
                <count group_id="O2" value="45"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100.7" spread="10.1"/>
                    <measurement group_id="O2" value="97.3" spread="7.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Post-prandial Blood Glucose</title>
        <description>Mean post-prandial blood glucose in pregnancy, as defined as the sum of the average post-prandial blood glucose at each visit divided by the number of visits.</description>
        <time_frame>up to 41 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Insulin NPH</title>
            <description>Insulin neutral protamine Hagedorn</description>
          </group>
          <group group_id="O2">
            <title>Levemir</title>
            <description>Insulin detemir (IDet)</description>
          </group>
        </group_list>
        <measure>
          <title>Post-prandial Blood Glucose</title>
          <description>Mean post-prandial blood glucose in pregnancy, as defined as the sum of the average post-prandial blood glucose at each visit divided by the number of visits.</description>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="42"/>
                <count group_id="O2" value="45"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="115.2" spread="10.2"/>
                    <measurement group_id="O2" value="112.9" spread="8.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Weight Gain</title>
        <description>Total weight gain in pregnancy</description>
        <time_frame>Number of pounds gained at each visit up to 41 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Insulin NPH</title>
            <description>Insulin neutral protamine Hagedorn</description>
          </group>
          <group group_id="O2">
            <title>Levemir</title>
            <description>Insulin detemir (IDet)</description>
          </group>
        </group_list>
        <measure>
          <title>Weight Gain</title>
          <description>Total weight gain in pregnancy</description>
          <units>lbs</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="42"/>
                <count group_id="O2" value="45"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="27.7" spread="15.3"/>
                    <measurement group_id="O2" value="28.6" spread="11.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Neonatal Weight</title>
        <description>Neonatal weight was estimated for occurrence of neonatal macrosomia (≥4000g birth weight) and neonatal LGA(large for gestational age)(birth weight &gt;90th percentile for gestational age</description>
        <time_frame>At delivery, up to 41 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Insulin NPH</title>
            <description>Insulin neutral protamine Hagedorn</description>
          </group>
          <group group_id="O2">
            <title>Levemir</title>
            <description>Insulin detemir (IDet)</description>
          </group>
        </group_list>
        <measure>
          <title>Neonatal Weight</title>
          <description>Neonatal weight was estimated for occurrence of neonatal macrosomia (≥4000g birth weight) and neonatal LGA(large for gestational age)(birth weight &gt;90th percentile for gestational age</description>
          <units>g</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="42"/>
                <count group_id="O2" value="45"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3230" lower_limit="2860" upper_limit="3530"/>
                    <measurement group_id="O2" value="3235" lower_limit="2670" upper_limit="3620"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Gestational Age at Delivery</title>
        <description>Gestational age at delivery</description>
        <time_frame>at delivery, up to 41 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Insulin NPH</title>
            <description>Insulin neutral protamine Hagedorn</description>
          </group>
          <group group_id="O2">
            <title>Levemir</title>
            <description>Insulin detemir (IDet)</description>
          </group>
        </group_list>
        <measure>
          <title>Gestational Age at Delivery</title>
          <description>Gestational age at delivery</description>
          <units>weeks</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="42"/>
                <count group_id="O2" value="45"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="38.9" lower_limit="37.6" upper_limit="39.3"/>
                    <measurement group_id="O2" value="38.8" lower_limit="38.1" upper_limit="39.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Maternal Hypoglycemia</title>
        <description>Number of participants with incidence of maternal hypoglycemia (&lt;60mg/dl)</description>
        <time_frame>at delivery, up to 41 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Insulin NPH</title>
            <description>Insulin neutral protamine Hagedorn</description>
          </group>
          <group group_id="O2">
            <title>Levemir</title>
            <description>Insulin detemir (IDet)</description>
          </group>
        </group_list>
        <measure>
          <title>Maternal Hypoglycemia</title>
          <description>Number of participants with incidence of maternal hypoglycemia (&lt;60mg/dl)</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="42"/>
                <count group_id="O2" value="45"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11"/>
                    <measurement group_id="O2" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Neonatal Bilirubin</title>
        <description>Percentage of neonatal hyperbilirubinemia - data not collected</description>
        <time_frame>at birth, up to 41 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Insulin NPH</title>
            <description>Insulin neutral protamine Hagedorn</description>
          </group>
          <group group_id="O2">
            <title>Levemir</title>
            <description>Insulin detemir (IDet)</description>
          </group>
        </group_list>
        <measure>
          <title>Neonatal Bilirubin</title>
          <description>Percentage of neonatal hyperbilirubinemia - data not collected</description>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Intensive Care Admissions</title>
        <description>Number of participants with incidence of neonatal intensive care unit admissions</description>
        <time_frame>at birth, up to 41 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Insulin NPH</title>
            <description>Insulin neutral protamine Hagedorn</description>
          </group>
          <group group_id="O2">
            <title>Levemir</title>
            <description>Insulin detemir (IDet)</description>
          </group>
        </group_list>
        <measure>
          <title>Intensive Care Admissions</title>
          <description>Number of participants with incidence of neonatal intensive care unit admissions</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="42"/>
                <count group_id="O2" value="45"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Delivery Mode</title>
        <description>method of delivery including cesarean section, vaginal delivery, or assisted vaginal delivery - data not collected</description>
        <time_frame>at birth, up to 41 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Insulin NPH</title>
            <description>Insulin neutral protamine Hagedorn</description>
          </group>
          <group group_id="O2">
            <title>Levemir</title>
            <description>Insulin detemir (IDet)</description>
          </group>
        </group_list>
        <measure>
          <title>Delivery Mode</title>
          <description>method of delivery including cesarean section, vaginal delivery, or assisted vaginal delivery - data not collected</description>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Birth Rate</title>
        <description>Number of live birth rate</description>
        <time_frame>at birth, up to 41 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Insulin NPH</title>
            <description>Insulin neutral protamine Hagedorn</description>
          </group>
          <group group_id="O2">
            <title>Levemir</title>
            <description>Insulin detemir (IDet)</description>
          </group>
        </group_list>
        <measure>
          <title>Birth Rate</title>
          <description>Number of live birth rate</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="42"/>
                <count group_id="O2" value="45"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="42"/>
                    <measurement group_id="O2" value="45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Shoulder Dystocia</title>
        <description>Incidence of shoulder dystocia - data not collected</description>
        <time_frame>at birth, up to 41 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Insulin NPH</title>
            <description>Insulin neutral protamine Hagedorn</description>
          </group>
          <group group_id="O2">
            <title>Levemir</title>
            <description>Insulin detemir (IDet)</description>
          </group>
        </group_list>
        <measure>
          <title>Shoulder Dystocia</title>
          <description>Incidence of shoulder dystocia - data not collected</description>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Polyhydramnios</title>
        <description>Incidence of polyhydramnios (defined as amniotic fluid index (AFI)&gt;20 or deepest vertical pocket ≥8) - data not collected</description>
        <time_frame>at each visit in pregnancy up to 41 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Insulin NPH</title>
            <description>Insulin neutral protamine Hagedorn</description>
          </group>
          <group group_id="O2">
            <title>Levemir</title>
            <description>Insulin detemir (IDet)</description>
          </group>
        </group_list>
        <measure>
          <title>Polyhydramnios</title>
          <description>Incidence of polyhydramnios (defined as amniotic fluid index (AFI)&gt;20 or deepest vertical pocket ≥8) - data not collected</description>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Neonatal Hypoglycemia</title>
        <description>Number of participants with incidence of blood sugar &lt;40mg/dl in neonate</description>
        <time_frame>at birth, up to 41 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Insulin NPH</title>
            <description>Insulin neutral protamine Hagedorn</description>
          </group>
          <group group_id="O2">
            <title>Levemir</title>
            <description>Insulin detemir (IDet)</description>
          </group>
        </group_list>
        <measure>
          <title>Neonatal Hypoglycemia</title>
          <description>Number of participants with incidence of blood sugar &lt;40mg/dl in neonate</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="42"/>
                <count group_id="O2" value="45"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Insulin NPH</title>
          <description>Insulin neutral protamine Hagedorn</description>
        </group>
        <group group_id="E2">
          <title>Levemir</title>
          <description>Insulin detemir (IDet)</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="52"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="53"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="52"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="53"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="27" subjects_at_risk="52"/>
                <counts group_id="E2" subjects_affected="45" subjects_at_risk="53"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Symptomatic hypoglycemia</sub_title>
                <counts group_id="E1" events="28" subjects_affected="11" subjects_at_risk="52"/>
                <counts group_id="E2" events="102" subjects_affected="16" subjects_at_risk="53"/>
              </event>
              <event>
                <sub_title>biochemical event of hypoglycemia</sub_title>
                <description>glucose &lt;60mg/dL regardless of presence or absence of symptoms</description>
                <counts group_id="E1" events="26" subjects_affected="14" subjects_at_risk="52"/>
                <counts group_id="E2" events="136" subjects_affected="27" subjects_at_risk="53"/>
              </event>
              <event>
                <sub_title>Symptomatic nocturnal event</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="52"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="53"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Rash</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="52"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="53"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Kimberly M. Herrera</name_or_title>
      <organization>Roosevelt Hospital, Mount Sinai Health System</organization>
      <email>kimmerher@gmail.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

